An underground market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these accounts privately for source information, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust trade exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering products of uncertain source.
Some professionals stated the popularity for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Material Elimination
According to the social media company, the service has removed violative material and prohibited related hashtags and search suggestions. The company said it was dedicated to maintaining the service safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at residence.
Within minutes of entering one group, a vendor shared contact information, where the majority of purchases take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Information and Costs
Within these communities, messages show black plastic packages with postal service labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the research behind this drug is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already encountered patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
